3.9 Article

POLQ suppresses genome instability and alterations in DNA repeat tract lengths

Journal

NAR CANCER
Volume 4, Issue 3, Pages -

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/narcan/zcac020

Keywords

-

Funding

  1. Cancer Research UK [A18246/A29202]
  2. Wales Cancer Research Centre
  3. National Cancer Institute [CA154461]
  4. National Institutes of Health General Medical Sciences [GM088351]

Ask authors/readers for more resources

DNA polymerase theta (POLQ) is a key enzyme involved in the repair of DNA double-strand breaks. Research has shown that cells lacking POLQ are resistant to growth deceleration during telomere-driven crisis, and exhibit longer telomeres and increased genetic heterogeneity.
DNA polymerase theta (POLQ) is a principal component of the alternative non-homologous end-joining (ANHEJ) DNA repair pathway that ligates DNA double-strand breaks. Utilizing independent models of POLQ insufficiency during telomere-driven crisis, we found that POLQ(-/-) cells are resistant to crisis-induced growth deceleration despite sustaining inter-chromosomal telomere fusion frequencies equivalent to wild-type (WT) cells. We recorded longer telomeres in POLQ(-/-) than WT cells pre- and post-crisis, notwithstanding elevated total telomere erosion and fusion rates. POLQ(-/-) cells emerging from crisis exhibited reduced incidence of clonal gross chromosomal abnormalities in accordance with increased genetic heterogeneity. High-throughput sequencing of telomere fusion amplicons from POLQ-deficient cells revealed significantly raised frequencies of inter-chromosomal fusions with correspondingly depreciated intrachromosomal recombinations. Long-range interactions culminating in telomere fusions with centromere alpha-satellite repeats, as well as expansions in HSAT2 and HSAT3 satellite and contractions in ribosomal DNA repeats, were detected in POLQ(-/-) cells. In conjunction with the expanded telomere lengths of POLQ(-/-) cells, these results indicate a hitherto unrealized capacity of POLQ for regulation of repeat arrays within the genome. Our findings uncover novel considerations for the efficacy of POLQ inhibitors in clinical cancer interventions, where potential genome destabilizing consequences could drive clonal evolution and resistant disease. [GRAPHICS] .

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available